The Secretary of the Development Headquarters of Life Sciences and Stem Cell Technologies stated that Iran's share of the global vaccine market is about half a percent, adding that a significant portion of this share is dedicated to meeting domestic needs, and we do not have substantial exports in this area; therefore, increasing Iran's share of the global market and developing exports should be prioritized.
ISNA is a semi-official Iranian news agency (Iranian Students News Agency). This is a translation of that outlet's own report; it is the outlet's account, not Artesh's finding.
See what Iranian state media is saying today.
❓ Unknown
Iran's share of the global vaccine market is half a percent / Investment of one billion for two strategic vaccines
9h ago
November 1, 2026
1 min read
📰 ISNA
📋 Key Takeaway
Iran currently holds a mere half percent of the global vaccine market, primarily focused on domestic needs rather than exports. The government is emphasizing the need to boost this share and enhance export capabilities.
🔍 Quick Context Guide
💡 Bottom Line:
Iran aims to enhance its vaccine market share to improve domestic health security and boost exports.
👥 Key Players
Secretary of the Development Headquarters of Life Sciences and Stem Cell Technologies
MENTIONED
Government official overseeing vaccine development
"They play a crucial role in shaping Iran's health policies and vaccine production capabilities."
📰 What Happened
Iran's Secretary of the Development Headquarters announced that the country's share of the global vaccine market is only half a percent, primarily focused on domestic needs. The government is prioritizing increasing this share and enhancing export capabilities.
- Iran's vaccine market share is approximately 0.5%.
- The majority of vaccine production is aimed at fulfilling domestic requirements.
💡 Why It Matters
🇮🇷 For Iran: Boosting vaccine production and exports could enhance Iran's self-sufficiency and economic resilience.
🌍 Regional: Improved vaccine capabilities could lead to better health outcomes in the region, potentially reducing reliance on foreign vaccines.
🌐 International: Increased exports may alter Iran's economic interactions and could impact global vaccine distribution dynamics.
📚 Background
Iran has historically faced challenges in its pharmaceutical sector due to sanctions and limited access to global markets. The COVID-19 pandemic highlighted the need for self-sufficiency in health care.
Vaccine production
Health policy in Iran
📡 Source:
STATE MEDIA
📊 Confidence:
70%
This source is likely to reflect government priorities and may emphasize positive developments in Iran's health sector.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%
📰 Related Coverage
Just now •
IRGC Navy Reports Explosions of Two Oil Tankers in Strait of Hormuz
18 min ago •
Two Oil Tankers Explode After Striking Naval Mines in Hormuz Strait
24 min ago •
Mohammad ElBaradei Warns Trump Against Any New Military Adventures Against Iran
31 min ago •
The Uncertainty of Supportive Housing Projects Must Be Resolved
38 min ago •